Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue 10, 2009, Pages 857-862

  Alexioy, Eleni ^a,b   Trakakis, Eftihios ^a,b   Kassanos, Demetrios ^b   Farmakidis, George ^c   Kondylios, Antonios ^c   Laggas, Demetrios ^a   Salamalekis, Emmanuel ^b   Florentin, Lia ^d   Kanavakis, Emmanuel ^b   Basios, George ^b   Trompoukis, Pantelis ^b   Georgiadoy, Lina ^a   Panagiotopoulos, Takis ^a  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Maternity and Children's Hospital   (Greece)

^d Alfalab Molecular Biology and Cytogenetics Center   (Greece)

Author keywords

Invasive prenatal control; Nuchal translucency; Predictive value

Indexed keywords

ADOLESCENT; ADULT; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; DOWN SYNDROME; EMBRYO; FEMALE; FETUS; HUMAN; KARYOTYPE 45,X; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PATAU SYNDROME; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; TRISOMY 13; TRISOMY 21; TURNER SYNDROME;

ADOLESCENT; ADULT; AMNIOCENTESIS; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DOWN SYNDROME; FEMALE; FETAL DISEASES; GONADAL DYSGENESIS; HUMANS; MATERNAL AGE; MIDDLE AGED; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; YOUNG ADULT;

EID: 70350666578     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050902994572     Document Type: Article

References (30)

1. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 week of gestation. Lancet 1998;351:343-346.
2. Nicolaides KH, Sebire J. Neil, Snijders RJM. The 11-14 week scan - chapter 1.3. Available: http://www.fetalmedicine.com via the INTERNET. Accessed 2007.
3. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45-46.
4. Chasen ST, Sharma G, Kalish RB, Chervenak FA. Firsttrimester screening for aneuploidy with fetal nuchal translucency in a United States population. Ultrasound Obstet Gynecol 2003;22:149-151.
5. Comas C, Torrents M, Munoz A, Antolin E, Figueras F, EchevarriaM. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker? Obstet Gynecol 2002;100:648-654.
6. Von Kaisenberg CS, Gasiorek-Wiens A, Bielicki M, Bahlmann F, Meyberg H, Kossakiewicz A, Pruggmayer M, Kamin G, Fritzer E, Harris C, et al. German Speaking Down Syndrome Screening Group. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study. J Matern Fetal Neonatal Med 2002;12:89-94.
7. Prefumo F, Thilaganathan B. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening. Prenat Diagn 2002;22:917-918.
8. Panburana P, Ajjimakorn S, Tungkajiwangoon P. First trimester Down Syndrome screening by nuchal translucency in a Thai population. Int J Gynaecol Obstet 2001;75:311-312.
9. Zoppi MA, Ibba RM, Floris M, Monni G. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 2001;18:649-651.
10. Michailides GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001;17:102-105.
11. Souka AP, von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005;92:1005-1021.
12. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001;18:9-17.
13. Pandya PP, Snijders RJM, Johnson SJ, Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynecol 1995;102:957-962.
14. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45-67.
15. Thilaganathan B, Sairam S, Michailidis G, Wathen NC. First trimester nuchal translucency: effective routine screening for Down's syndrome. Br J Radiol 1999;72:946-948.
16. Theodoropoulos P, Lolis D, Papageorgiou C, Papaioannou S, Plachouras N, Makrydimas G. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age. Prenat Diagn 1998;18:133-137.
17. Pandya PP, Kondylios A, Hilbert L, Snijders RJM, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995;5:15-19.
18. Brambati B, Cislaghi C, Tuli L, Alberti E, Amidani M, Colombo U, Zuliani G. First trimester Down's syndrome screening using nuchal translucency: a prospective study. Ultrasound Obstet Gynecol 1995;5:9-14.
19. Comas C, Martinez JM, Ojuel J, Casal E, Puerto B, Borrell A, Fortuny A. First-trimester nuchal edema as a marker of aneuploidy. Ultrasound Obstet Gynecol 1995;5:26-29.
20. Pajkrt E, Mol BW, van Lith JM, Bleker OP, Bilardo CM. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population. Ultrasound Obstet Gynecol 1998;12:156-162. (Pubitemid 28474921)
21. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997;337:1654-1658.
22. Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation. Am J Med Genet 1999;86:205-207.
23. Sebire NJ, Snijders RJM, Davenport M, Greenough A, Nicolaides KH. Fetal nuchal translucency thickness at 10- 14 weeks of gestation and congenital diaphragmatic hernia. Obstet Gynecol 1997;90:943-947.
24. Ville Y, Lalondrelle C, Doumerc S, Daffos F, Frydman R, Oury JF, Dumez Y. First-trimester diagnosis of nuchal anomalies: significance and fetal outcome. Ultrasound Obstet Gynecol 1992;2:314-316.
25. Szabo J, Gellen J, Szemere G, First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age. Ultrasound Obstet Gynecol 1995;5:3161-3163.
26. Savoldelli G, Binkert F, Achermann J, Schmid W. Ultrasound screening for chromosomal anomalies in the first trimester of pregnancy. Prenat Diagn 1993;13:513-518.
27. Van Zalen-Sprock MM, Van Vugt JMG, Van Geijn HP. Firsttrimester diagnosis of cystic hygroma- course and outcome. Am J Obstet Gynecol 1992;167:94-98.
28. Suchet IB, Van Der Westhuizen NG, Labatte MF. Fetal cystic hygromas: further insights into their natural history. Can Assoc Radiol J 1992;6:420-424.
29. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867-869.
30. Nicolaides KH, Brizot ML, Patel F, Snijders RJM. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10 - 13 weeks gestation. Lancet 1994;344:435-439.